EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Molecular predictors of recurrence in vestibular schwannomas: a transcriptomic and RT-qPCR analysis

Carmen Ruiz-García, Sandra Franco-Caspueñas, Lourdes Rodríguez-de la Rosa, Victor Martinez-Glez, J Manuel Morales-Puebla, Isabel Varela-Nieto, Luis Lassaletta

European Archives of Oto-Rhino-Laryngology · 2026-10 · 283 (12) · 7741-7752

DOI: 10.1007/s00405-026-10548-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Archives of Oto-Rhino-Laryngology, online erschienen am 26.08.2026. Verfasst von Carmen Ruiz-García und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, La Paz University Hospital, Paseo de la Castellana 261, 28046, Madrid, Spain. carmen.ruizg@estudiante.uam.es. Hauptthemen laut MEDLINE: Neuroma, Acoustic, Neoplasm Recurrence, Local. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidad Autónoma de Madrid.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Vestibular schwannomas (VS) are benign tumors with variable clinical behavior. Recurrence after surgery is uncommon yet sometimes aggressive. Reliable molecular predictors of recurrence are lacking, and the correlation between genotype and phenotype is weak. This study aimed to identify molecular markers associated with recurrence in VS and explore their prognostic potential.

Methods

Retrospective case-control study of patients undergoing VS surgery between 2017 and 2024. RNA-Seq was conducted to identify molecular signatures associated with recurrence, and selected genes were validated using RT-qPCR. Recurrence-free and salvage surgery-free survival were analyzed by the extent of resection.

Results

23 samples from 22 patients were analyzed, including 7 recurrent and 16 non-recurrent cases. 81 differentially expressed genes were identified in recurrent tumors, with enrichment of the MAPK (FDR = 7.9 × 10⁻⁴) and PI3K/AKT/mTOR (FDR = 0.038) pathways. Eight candidate genes were selected for validation: DCN (FC 4.34); DUSP5 (FC 4.20); CXCL8 (FC 3.25); JUND (FC 3.27); MYC (FC 2.45); MAFF (FC 3.79); SOD3 (FC 2.47) (all upregulated), and TNF (FC 0.16) (downregulated). RT-qPCR confirmed that CXCL8 and TNF were significantly elevated in tumors requiring early salvage surgery and in an NF2-associated Schwannomatosis case. No differences in recurrence-free or salvage surgery-free survival were observed between near-total and subtotal resections.

Conclusion

Recurrent VS exhibit a distinct molecular profile, highlighting IL-8 and TNFα as potential biomarkers and therapeutic targets. These findings support the development of a prognostic panel to guide personalized follow-up and treatment, particularly for high-risk patients. Further studies are needed before clinical implementation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuroma, AcousticNeoplasm Recurrence, LocalHumansFemaleRetrospective StudiesMaleMiddle AgedCase-Control StudiesBiomarkers, TumorAdultTranscriptomeAgedPrognosisReal-Time Polymerase Chain ReactionGene Expression Profiling

Stichwörter der Autor:innen

Acoustic neuromaGene expression profilingInterleukin-8NF2-associated schwannomatosisTumor biologyTumor necrosis factor

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Otorhinolaryngology, La Paz University Hospital, Paseo de la Castellana 261, 28046, Madrid, Spain. carmen.ruizg@estudiante.uam.es.
  • Neurobiology of Hearing and Myelinopathies, Institute for Biomedical Research Sols-Morreale (IIBM), CSIC-UAM, Arturo Duperier 4, 28029, Madrid, Spain. carmen.ruizg@estudiante.uam.es.
  • Research in Otoneurosurgery, Hospital La Paz Institute for Health Research - IdiPAZ, Paseo de la Castellana 261, 28046, Madrid, Spain. carmen.ruizg@estudiante.uam.es.
  • PhD Program in Medicine and Surgery, Faculty of Medicine, Autonomous University of Madrid, Arzobispo Morcillo 4, 28029, Madrid, Spain. carmen.ruizg@estudiante.uam.es.
  • Neurobiology of Hearing and Myelinopathies, Institute for Biomedical Research Sols-Morreale (IIBM), CSIC-UAM, Arturo Duperier 4, 28029, Madrid, Spain.
  • Research in Otoneurosurgery, Hospital La Paz Institute for Health Research - IdiPAZ, Paseo de la Castellana 261, 28046, Madrid, Spain.

Förderung

  • Universidad Autónoma de Madrid

Zitieren

APA

Ruiz-García, C., Franco-Caspueñas, S., Rodríguez-de la Rosa, L., Martinez-Glez, V., Morales-Puebla, J. M., Varela-Nieto, I., & Lassaletta, L. (2026). Molecular predictors of recurrence in vestibular schwannomas: a transcriptomic and RT-qPCR analysis. European Archives of Oto-Rhino-Laryngology, 283(12), 7741-7752. https://doi.org/10.1007/s00405-026-10548-7

Vancouver

Ruiz-García C, Franco-Caspueñas S, Rodríguez-de la Rosa L, Martinez-Glez V, Morales-Puebla JM, Varela-Nieto I, et al. Molecular predictors of recurrence in vestibular schwannomas: a transcriptomic and RT-qPCR analysis. European Archives of Oto-Rhino-Laryngology. 2026;283(12):7741-7752. doi:10.1007/s00405-026-10548-7

BibTeX
@article{RuizGarca2026,
  author = {Ruiz-García, Carmen and Franco-Caspueñas, Sandra and Rodríguez-de la Rosa, Lourdes and Martinez-Glez, Victor and Morales-Puebla, J Manuel and Varela-Nieto, Isabel and Lassaletta, Luis},
  title = {Molecular predictors of recurrence in vestibular schwannomas: a transcriptomic and RT-qPCR analysis},
  journal = {European Archives of Oto-Rhino-Laryngology},
  year = {2026},
  volume = {283},
  number = {12},
  pages = {7741--7752},
  doi = {10.1007/s00405-026-10548-7}
}
Kostenlos starten →